News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alzheon To Present At Cowen and Company 34th Annual Health Care Conference



3/3/2014 7:47:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, today announced that it will present at the Cowen & Company 34th Annual Health Care Conference at 12:00 noon ET on Monday, March 3, 2014, at the Boston Marriott Copley Place in Boston, MA. Martin Tolar, MD, PhD, Founder, President and CEO of Alzheon, will present at the conference to provide an overview of Alzheon’s drug development pipeline in Alzheimer’s disease, including ALZ-801, the company’s lead clinical candidate starting confirmatory pivotal Phase 2/3 study in early 2015 in Alzheimer’s disease patients positive for e4 allele of the apolipoprotein E. The presentation will be available on Alzheon’s website www.alzheon.com, under Press Releases.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES